Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Current Deferred Revenue (2020 - 2024)

National Healthcare (NHC) has disclosed Current Deferred Revenue for 6 consecutive years, with $7.7 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Current Deferred Revenue changed N/A year-over-year to $7.7 million, compared with a TTM value of $7.7 million through Mar 2024, changed N/A, and an annual FY2021 reading of $15.0 million, down 70.69% over the prior year.
  • Current Deferred Revenue was $7.7 million for Q1 2024 at National Healthcare, up from $138000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $51.3 million in Q3 2020 and bottomed at $138000.0 in Q3 2022.
  • Average Current Deferred Revenue over 4 years is $27.3 million, with a median of $27.0 million recorded in 2021.
  • The sharpest move saw Current Deferred Revenue fell 21.32% in 2021, then plummeted 99.49% in 2022.
  • Year by year, Current Deferred Revenue stood at $51.3 million in 2020, then plummeted by 70.69% to $15.0 million in 2021, then tumbled by 99.08% to $138000.0 in 2022, then skyrocketed by 5455.8% to $7.7 million in 2024.
  • Business Quant data shows Current Deferred Revenue for NHC at $7.7 million in Q1 2024, $138000.0 in Q3 2022, and $586000.0 in Q2 2022.